|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Department of Dermatology, University of Cincinnati College of Medicine, PO
Box 670592, Cincinnati, Ohio 45267-0592, USA
2 Fujita Health University School of Health Sciences, Toyoake, Aichi 470-1192,
Japan
3 Department of Dermatology, Nara Medical University, Kashihara, Nara 634-8522,
Japan
4 Department of Molecular Genetics, Biochemistry and Microbiology, University of
Cincinnati College of Medicine, PO Box 670524, Cincinnati, Ohio 45267-0524,
USA
5 POLA Laboratories, 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812, Japan
6 Laboratory of Cell Biology, National Cancer Institute, National Institutes of
Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
* Author for correspondence (e-mail: abdelmza{at}email.uc.edu )
Accepted 6 March 2002
Cutaneous pigmentation is determined by the amounts of eumelanin and
pheomelanin synthesized by epidermal melanocytes and is known to protect
against sun-induced DNA damage. The synthesis of eumelanin is stimulated by
the binding of
-melanotropin (
-melanocyte-stimulating hormone)
to the functional melanocortin 1 receptor (MC1R) expressed on melanocytes. The
human MC1R gene is highly polymorphic and certain allelic variants of
the gene are associated with red hair phenotype, melanoma and non-melanoma
skin cancer. The importance of the MC1R gene in determining skin
cancer risk led us to examine the impact of specific polymorphisms in this
gene on the responses of human melanocytes to
-melanotropin and UV
radiation. We compared the ability of human melanocyte cultures, each derived
from a single donor, to respond to
-melanotropin with dose-dependent
stimulation of cAMP formation, tyrosinase activity and proliferation. In each
of those cultures the MC1R gene was sequenced, and the eumelanin and
pheomelanin contents were determined. Human melanocytes homozygous for
Arg160Trp, heterozygous for Arg160Trp and Asp294His, or for Arg151Cys and
Asp294His substitutions, but not melanocytes homozygous for Val92Met
substitution, in the MC1R demonstrated a significantly reduced response to
-melanotropin. Additionally, melanocytes with a non-functional MC1R
demonstrated a pronounced increase in their sensitivity to the cytotoxic
effect of UV radiation compared with melanocytes expressing functional MC1R.
We conclude that loss-of-function mutations in the MC1R gene
sensitize human melanocytes to the DNA damaging effects of UV radiation, which
may increase skin cancer risk.
Key words: Melanocortin 1 receptor, Human melanocytes, MC1R variants
This article has been cited by other articles:
![]() |
T. Dwyer, I. van der Mei, A-L Ponsonby, B. V. Taylor, J. Stankovich, J. D. McKay, R. J. Thomson, A. M. Polanowski, and J. L. Dickinson Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis Neurology, August 19, 2008; 71(8): 583 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Smith, N. Luk, R. A. Newton, D. W. Roberts, R. A. Sturm, and G. E. O. Muscat Melanocortin-1 Receptor Signaling Markedly Induces the Expression of the NR4A Nuclear Receptor Subgroup in Melanocytic Cells J. Biol. Chem., May 2, 2008; 283(18): 12564 - 12570. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Meyskens Jr. and M. Berwick UV or Not UV: Metals Are The Answer Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 268 - 270. [Full Text] [PDF] |
||||
![]() |
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, D.-N. Hu, H. Zhao, S. A. McCormick, J. J. Nordlund, and R. E. Boissy Uveal Melanocytes Do Not Respond To or Express Receptors for {alpha}-Melanocyte-Stimulating Hormone. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4507 - 4512. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rouzaud, G.-E. Costin, Y. Yamaguchi, J. C. Valencia, W. F. Berens, K. G. Chen, T. Hoashi, M. Bohm, Z. A. Abdel-Malek, and V. J. Hearing Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms FASEB J, September 1, 2006; 20(11): 1927 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Landi, J. Bauer, R. M. Pfeiffer, D. E. Elder, B. Hulley, P. Minghetti, D. Calista, P. A. Kanetsky, D. Pinkel, and B. C. Bastian MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma Science, July 28, 2006; 313(5786): 521 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Abdel-Malek, A. L. Kadekaro, R. J. Kavanagh, A. Todorovic, L. N. Koikov, J. C. McNulty, P. J. Jackson, G. L. Millhauser, S. Schwemberger, G. Babcock, et al. Melanoma prevention strategy based on using tetrapeptide {alpha}-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity FASEB J, July 1, 2006; 20(9): 1561 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chaudru, K. Laud, M.-F. Avril, A. Miniere, A. Chompret, B. Bressac-de Paillerets, F. Demenais, and The French Familial Melanoma Study Group Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2384 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Beaumont, R. A. Newton, D. J. Smit, J. H. Leonard, J. L. Stow, and R. A. Sturm Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk Hum. Mol. Genet., August 1, 2005; 14(15): 2145 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Landi, P. A. Kanetsky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, J. Swoyer, M. Ter-Minassian, M. Hedayati, L. Grossman, et al. MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean Population J Natl Cancer Inst, July 6, 2005; 97(13): 998 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Kadekaro, R. Kavanagh, H. Kanto, S. Terzieva, J. Hauser, N. Kobayashi, S. Schwemberger, J. Cornelius, G. Babcock, H. G. Shertzer, et al. {alpha}-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes Cancer Res., May 15, 2005; 65(10): 4292 - 4299. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Duffy, N. F. Box, W. Chen, J. S. Palmer, G. W. Montgomery, M. R. James, N. K. Hayward, N. G. Martin, and R. A. Sturm Interactive effects of MC1R and OCA2 on melanoma risk phenotypes Hum. Mol. Genet., February 15, 2004; 13(4): 447 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Matichard, P Verpillat, R Meziani, B Gerard, V Descamps, E Legroux, M Burnouf, G Bertrand, F Bouscarat, A Archimbaud, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure J. Med. Genet., February 1, 2004; 41(2): e13 - 13. [Full Text] [PDF] |
||||
![]() |
J. S. Mogil, S. G. Wilson, E. J. Chesler, A. L. Rankin, K. V. S. Nemmani, W. R. Lariviere, M. K. Groce, M. R. Wallace, L. Kaplan, R. Staud, et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans PNAS, April 15, 2003; 100(8): 4867 - 4872. [Abstract] [Full Text] [PDF] |
||||